These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23806267)

  • 21. Myopericarditis following smallpox vaccination.
    Arness MK; Eckart RE; Love SS; Atwood JE; Wells TS; Engler RJ; Collins LC; Ludwig SL; Riddle JR; Grabenstein JD; Tornberg DN
    Am J Epidemiol; 2004 Oct; 160(7):642-51. PubMed ID: 15383408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulator-based enhancement of anti smallpox immune responses.
    Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
    PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide genetic associations with IFNγ response to smallpox vaccine.
    Kennedy RB; Ovsyannikova IG; Pankratz VS; Haralambieva IH; Vierkant RA; Jacobson RM; Poland GA
    Hum Genet; 2012 Sep; 131(9):1433-51. PubMed ID: 22661280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
    Parrino J; McCurdy LH; Larkin BD; Gordon IJ; Rucker SE; Enama ME; Koup RA; Roederer M; Bailer RT; Moodie Z; Gu L; Yan L; Graham BS;
    Vaccine; 2007 Feb; 25(8):1513-25. PubMed ID: 17126963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
    Umlauf BJ; Haralambieva IH; Ovsyannikova IG; Kennedy RB; Pankratz VS; Jacobson RM; Poland GA
    Viral Immunol; 2012 Feb; 25(1):29-36. PubMed ID: 22239234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
    Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
    Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
    Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
    J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
    Meseda CA; Mayer AE; Kumar A; Garcia AD; Campbell J; Listrani P; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Clin Vaccine Immunol; 2009 Sep; 16(9):1261-71. PubMed ID: 19605597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J; Wu H; Liang H; Topham DJ
    Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
    Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
    JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.
    Wei H; Huang D; Fortman J; Wang R; Shao L; Chen ZW
    J Virol; 2009 Jan; 83(2):1115-25. PubMed ID: 19004937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.
    Frey SE; Winokur PL; Salata RA; El-Kamary SS; Turley CB; Walter EB; Hay CM; Newman FK; Hill HR; Zhang Y; Chaplin P; Tary-Lehmann M; Belshe RB
    Vaccine; 2013 Jun; 31(29):3025-33. PubMed ID: 23664987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
    Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
    N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels.
    Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
    J Infect Dis; 2004 Apr; 189(8):1401-10. PubMed ID: 15073677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular complications in the Department of Defense Smallpox Vaccination Program.
    Fillmore GL; Ward TP; Bower KS; Dudenhoefer EJ; Grabenstein JD; Berry GK; Madigan WP
    Ophthalmology; 2004 Nov; 111(11):2086-93. PubMed ID: 15522376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.
    Kennedy RB; Poland GA; Ovsyannikova IG; Oberg AL; Asmann YW; Grill DE; Vierkant RA; Jacobson RM
    Vaccine; 2016 Jun; 34(28):3283-90. PubMed ID: 27177944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
    Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
    Grosenbach DW; Jordan R; King DS; Berhanu A; Warren TK; Kirkwood-Watts DL; Tyavanagimatt S; Tan Y; Wilson RL; Jones KF; Hruby DE
    Vaccine; 2008 Feb; 26(7):933-46. PubMed ID: 18226434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of vaccinia dissemination despite lack of major reaction following smallpox vaccination.
    Delacruz WP; Savona MR; Thornton JA; Danaher PJ
    Vaccine; 2020 Feb; 38(7):1589-1592. PubMed ID: 31899026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.